In this video, Dr. Leonard Javier reviews 14 randomized controlled clinical trials on okra (Abelmoschus esculentus) and insulin resistance. Learn the four mechanisms by which okra reverses insulin resistance, why your endocrinologist has never mentioned it, and exactly how to use it safely alongside your current diabetes medication. TIMESTAMPS: 0:00 — 14 clinical trials. 836 patients. One vegetable. 1:20 — The charge: insulin resistance has a $67B pharmaceutical solution... and a $0.67 alternative 6:00 — Exhibit A: The clinical evidence from 14 randomized controlled trials 14:00 — Exhibit B: 4 mechanisms — how okra reverses insulin resistance simultaneously 24:00 — The cross-examination: why your doctor never told you 30:00 — The verdict: exactly how to use okra (3 methods + 21-day protocol) 37:00 — 3 dangerous combinations to avoid 40:00 — The overnight insulin resistance problem nobody monitors
DISCLAIMER: This video is for educational purposes only. It does not constitute medical advice. Always consult your doctor before making changes to your health regimen. Okra supplementation should be used alongside, not instead of, prescribed diabetes medication.
All researches in the video are listed below: 1. Jafari S, et al. Therapeutic potential of okra (Abelmoschus esculentus) in dysglycaemia and metabolic dysfunction: A systematic review and meta-analysis across the diabetes spectrum. Experimental Physiology. 2025. https://physoc.onlinelibrary.wiley.com/doi/full/10.1113/EP093293 2. Tavakolizadeh M, et al. Clinical efficacy and safety of okra (Abelmoschus esculentus (L.) Moench) in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial. Acta Diabetologica. 2023;60(12):1685-1695. https://pubmed.ncbi.nlm.nih.gov/37507536/ 3. Bahari H, et al. The cardiometabolic benefits of okra-based treatment in prediabetes and diabetes: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Nutrition. 2024;11:1454286. https://pubmed.ncbi.nlm.nih.gov/39726865/ 4. Mokgalaboni K, et al. Okra ameliorates hyperglycaemia in pre-diabetic and type 2 diabetic patients: A systematic review and meta-analysis of the clinical evidence. Frontiers in Pharmacology. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10107009/ 5. Saatchi A, et al. Anti-hyperglycemic effect of Abelmoschus esculentus (Okra) on patients with diabetes type 2: a randomized clinical trial. Phytotherapy Research. 2022;36(4):1644-1651. https://pubmed.ncbi.nlm.nih.gov/35434945/ 6. Fan Y, et al. The Impact of Okra (Abelmoschus esculentus) Supplementation on Diabetes and Obesity Biomarkers in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Food Science & Nutrition. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12504793/ 7. The impact of okra on metabolic parameters in Type 2 diabetes patients: Results from a double-blind clinical trial. Obesity Medicine. 2025. https://www.sciencedirect.com/science/article/abs/pii/S2212958825000333 8. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-853. https://pubmed.ncbi.nlm.nih.gov/9742976/ 9. Afsharmanesh MR, et al. Okra (Abelmoschus esculentus) intake improves lipid profile and liver transaminases in pre-diabetic adults: a randomized double-blinded trial. Jundishapur J Nat Pharm Prod. 2023. 10. Nikpayam O, et al. The effect of Abelmoschus esculentus L. (okra) extract supplementation on dietary intake, appetite, anthropometric measures, and body composition in patients with diabetic nephropathy. Health Promotion Perspectives. 2022;12:169-177.
